Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer

Clinical trial NCT06439888 · RECRUITING

Trial details

NCT number: NCT06439888
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Oligometastatic Disease Solid Tumor, Adult

Start date: 2024-07-11
Primary completion: 2026-09-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.